Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
P2RY8
REST API REST API
Homo sapiens
P2RY8 is differentially expressed in 123 experiments: 63 organism parts: bone marrow, spleen, ... (61 more);, 75 disease states: normal, glioblastoma, ... (73 more);, 54 cell types 266 cell lines 12 compound treatments and 41 other conditions.
Synonyms P2Y8
Orthologs P2RY8_CHICK (Gallus gallus)   p2ry8 (Danio rerio)   LOC100487194 (Xenopus laevis)   P2RY8 (Canis familiaris)   P2RY8 (Bos taurus)   (Compare orthologs)
Gene Ontology Term plasma membrane, G-protein coupled receptor activity, G-protein coupled receptor protein signaling pathway, signal transducer activity, receptor activity, integral to membrane, purinergic nucleotide receptor activity, G-protein coupled
InterPro Term GPCR_Rhodpsn_supfam, Protea_act_rcpt, 7TM_GPCR_Rhodpsn, P2_purnocptor
UniProt Accession Q86VZ1
Search EB-eye ENSG00000182162
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-22541, E-GEOD-3526, ... (14 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-MTAB-37, E-GEOD-3202, E-GEOD-12662, E-GEOD-22152, E-GEOD-20089, ... (11 experiments)

Factor Value U/D Experiments
SW1116
1
E-MTAB-37
NCIH747
1
E-MTAB-37
NCIH720
1
E-MTAB-37
A204
1
E-MTAB-37
NCIH1651
1
E-MTAB-37
C7H2-R10E7
1
E-GEOD-22152
260 more value(s).


Cell type

studied in E-GEOD-18811, E-GEOD-22529, E-AFMX-5, E-GEOD-5099, E-GEOD-1460, ... (22 experiments)

Factor Value U/D Experiments
CD4+ T cell
2
E-AFMX-5, E-GEOD-16190
testis - germ cell
1
E-AFMX-5
adipocyte
1
E-AFMX-5
721 B lymphoblast
1
1
E-AFMX-5
CD19+ B cells (neg. sel.)
1
E-AFMX-5
B cell
1
1
E-GEOD-13987
48 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-22529, E-GEOD-22148, E-MEXP-2280, E-GEOD-9692, ... (26 experiments)

Factor Value U/D Experiments
glioblastoma
3
E-MTAB-37, E-GEOD-4412, E-GEOD-4290
gastric carcinoma
2
E-MTAB-37, E-GEOD-15460
leiomyoblastoma
1
E-MTAB-37
follicular hyperplasia
1
E-GEOD-7788
sarcoma
1
E-MTAB-37
rheumatoid arthritis
1
E-GEOD-7307
69 more value(s).


Compound treatment

studied in E-MEXP-1601, E-GEOD-7400, E-GEOD-3284, E-MEXP-1230, E-TABM-782, ... (11 experiments)

Factor Value U/D Experiments
granulocyte-colony stimulating factor
1
E-GEOD-7400
bacterial endotoxin
1
E-GEOD-3284
HMB-PP (phosphoantigen)
1
E-MEXP-1601
lipopolysaccharide
1
1
E-MEXP-1958, E-TABM-868
SDF
1
E-GEOD-7307
not specified
1
E-GEOD-20081
6 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19246, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-4667

Disease staging
studied in E-GEOD-19743, E-GEOD-22541, E-GEOD-22148, E-MEXP-2280, E-GEOD-21138 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-17385

Genotype
studied in E-GEOD-17476, E-MEXP-421, E-TABM-868, E-MEXP-1403

Growth condition
studied in E-GEOD-12773, E-MEXP-2146

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-740, E-MEXP-2069, E-TABM-666, ... (18 experiments)

Infection
studied in E-GEOD-12108

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Localisation of metastases
studied in E-GEOD-22541

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Phenotype
studied in E-GEOD-26495, E-GEOD-19703, E-MEXP-1412, E-GEOD-1460, E-GEOD-17636, ... (6 experiments)

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19246

Replicate
studied in E-GEOD-10896

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743

Sex
studied in E-GEOD-19069

Stimulation
studied in E-GEOD-20114, E-GEOD-12710

stimulus
studied in E-GEOD-22103

Stimulus or stress
studied in E-GEOD-7538

Subtype
studied in E-GEOD-24283

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-MEXP-973

Tumor grading
studied in E-GEOD-22541

Processing time: 0.571 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM